G, N, and P Gene-based Analysis of Chandipura Viruses, India by Avinash, Arankalle Vidya et al.





Vidya Avinash Arankalle,* Shrotri Sandhya
Prabhakar,* Walimbe Atul Madhukar,*
Hanumaih,* Pawar Shailesh Dattatraya,* 
and Mishra Akhilesh Chandra*
An encephalitis outbreak in 2003 in children from India
was attributed to Chandipura virus. Sequence analyses of
G, N, and P genes showed 95.6%–97.6% nucleotide iden-
tity with the 1965 isolate (G gene, 7–11 amino acid
changes); N and P genes were highly conserved. 
C
handipura virus (CHPV, family Rhabdoviridae), was
implicated as the cause of a large outbreak of
encephalitis in children, involving 329 cases with 183
deaths, from Andhra Pradesh State, India in 2003 (1). On
the basis of serologic investigations conducted during the
epidemic, CHPV infection led to different clinical mani-
festations, including subclinical cases, mild fever, and
encephalitis; some patients died within 48 hours, while
others recovered (1). CHPV was described for the first
time in India in 1965, when it was isolated from the serum
of a patient with febrile illness (2) during an outbreak of
dengue and Chikungunya viruses. The virus was isolated
again in 1980 from an encephalopathy patient during an
outbreak in children (3). However, the magnitude of the
2003 outbreak was unique. The present study was conduct-
ed to understand the relationship of the 2003 isolates with
the 1965 strain and to assess association of mutations in G,
N, and P genes with different clinical manifestations. 
The Study
During the outbreak investigations, 5 CHPV isolates
were obtained in cell culture. Table 1 provides details
about these isolates. The 1980 isolate was not available for
further analysis. These isolates were subjected to reverse
transcription–polymerase chain reaction (RT-PCR),
according to the previously described method (1). The
primers listed in Table 2 were designed on the basis of pub-
lished sequences and used to amplify and sequence the G,
P, and N genes (4,5). The PCR products were purified by
using Wizard PCR preps DNA purification Kit (Promega,
Madison,WI) and sequenced by using Big Dye Terminator
cycle sequencing Ready Reaction Kit (Applied
Biosystems, Foster City, CA) and an automatic sequencer
(ABI PRISM 310 Genetic Analyzer, Applied Biosystems).
Multiple alignment of nucleotide/amino acid sequences
was carried out by using software ClustalX v.1.83.
Phylogenetic analyses based on the G, N, and P genes
(1593, 1269, 882 nucleotides [nt], respectively) were car-
ried out employing maximum likelihood method in
Phylo_win software (6). The reliability of different phylo-
genetic groupings was evaluated by using the bootstrap
test, with 1,000 bootstrap replications, available in
Phylo_win. CHPV sequences representing 3 encephalitis
cases, including 1 fatal case (patient 2, Table) and 2 febrile
cases, were compared.
G gene analysis led to the correction of the sequence
reported for the 1965 isolate (accession no. J04350). As
compared to the 1965 isolate, the only sequence available
in the GenBank database, the following differences were
noted for all the 2003 epidemic isolates: 1) an addition of
17 nt after position 1457 base; 2) additions at positions
804, 902, and 1558; and 3) deletions at positions 854 and
869. To confirm these mutations, we sequenced the 1965
isolate available with the repository of the institute and
noted that the 1965 sequence did not exhibit the deletions
or additions mentioned above. The corrected 1965-CHP-G
gene sequence was deposited in GenBank (accession no.
AY614717) and used for comparisons. When compared
with the corrected sequence, the 2003 epidemic isolates
did not exhibit the mutations mentioned above. Although
Walker and Kongsuwan resequenced part of the G gene of
the 1965 isolate (262 nt) and made necessary corrections
(7), these were not deposited in GenBank.
The epidemic isolates exhibited 97% ± 0.3% nucleotide
identity (PNI) with each other and 95.6%–96.1% PNI with
the 1965 isolate. For CIN0360 and CIN0327 isolates,
grown in 2 different cell lines, the PNIs were 100% and
99.9%, respectively. Comparison of partial G gene
sequences from clinical samples (N = 3) with the corre-
sponding cell-line isolates documented that, although
sequences derived from different clinical samples exhibited
unique mutations, except for l substitution in CIN0331M
isolate (A1167C), no changes were noted (see online
Figure 1; available from http://www.cdc.gov/ncidod/ EID/
vol11no01/04-0602-G1.htm).
Alignment of deduced amino acid sequences of the G
protein (530 amino acids [aa]) from different isolates is
depicted in online Figure 2 (available from
http://www.cdc.gov/ncidod/EID/vol11no01/04-0602-
G2.htm). A total of 7 aa substitutions were noted for the
epidemic isolates: Leu19Ser, Tyr22Ser, Thr219Ala,
Gly222Ala, Arg264Lys, His269Pro, and Thr279Ala. In
addition, the brain-derived isolate exhibited 4 more
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 1, January 2005 123
*National Institute of Virology, Pune, Maharashtra, Indiasubstitutions: Ile16Val, Asn30Ser, Ile218Val, and Arg502-
Lys. This isolate did not replace Pro → Met at position 367
seen in other epidemic isolates. Two amino acid substitu-
tions (Lys40Arg and Leu424Val) were seen in the isolates
from encephalitis cases (CIN0327M and CIN0327R). One
isolate from a febrile patient, CIN0309R, showed an addi-
tional substitution, Asp213Val.
N gene analysis showed that the 1965 isolate was
96.5%–97.6% identical at the nucleotide level with the epi-
demic isolates, whereas the epidemic isolates were 97.7%
± 0.3% identical with each other. The isolates grown in dif-
ferent cell lines exhibited 99.3%–99.5% PNI. A single
amino acid substitution, Lys37Arg, was noted for all epi-
demic isolates (online Figure 3; available from
http://www.cdc.gov/ncidod/EID/vol11no01/04-0602-
G3.htm). In all isolates except CIN0331M, Asp substitut-
ed Glu at 364. Additional substitutions, Val413Ile
(brain-derived isolate) and Ala163Thr (CIN0309R, from a
febrile case), were present. 
For the P gene, among epidemic isolates, the PNI was
97.4% ± 0.4%, whereas 95.8%–96.8% identity was
observed with the 1965 isolate. The isolates grown in dif-
ferent cell lines were 99%–99.7% identical at the
nucleotide level. Glu64Asp substitution was present in all
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http://www.cdc.gov/ncidod/EID/vol11no01/04-0602-
G4.htm). A unique single amino acid substitution was
noted for 3 isolates: Gln103Arg in CIN0309R (febrile
case), Ile180Val in brain-derived isolates, and Asn257Thr
in CIN0327M (encephalitis case). In addition, Gly112Glu
substitution was recorded in 4 isolates (CIN0327R,
CIN0327M, CIN0309R, and CIN0331M); Ala214Val was
present in all except CIN0327R, CIN0360R, and Ile270Val
in 3 isolates (CIN0318R, CIN0309R, and CIN0331M).
The Figure presents the phylogenetic status of different
epidemic isolates. Overall, different CHPV isolates were
not very divergent from each other. For G and P
gene–based analyses, the brain-derived isolate was closer
to the 1965 isolate. No segregation of fever and encephali-
tis case-derived isolates was noted. Although the topology
for the unrooted N gene–based tree was similar, the 1965
isolate remained on a separate branch. 
Conclusions
This study showed that the 2003 epidemic isolates were
closely related to the 1965 isolate. PNIs were
95.6%–96.1% for the G gene, which is responsible for
virus entry into cells and induction of neutralizing antibod-
ies; 96.5%–97.6% for the N gene, mainly associated with
cytotoxic T-lymphocyte responses; and 95.8%–96.8% for
the P gene, associated with RNA polymerase. Thus, the
epidemic was not associated with extensive mutations in
these genes. Adaptation to cell cultures did not result in
changes in the partial G gene sequences, except for l nt
change (A to C at position 1167) for 1 isolate.
The comparison of the deduced amino acid sequences
of G protein of 1965 and 2003 isolates documented 7 dif-
ferences for the epidemic isolates. None of these were in
the transmembrane region sequence (482–502 aa) or in the
intracytoplasmic region sequence (503–530, the carboxyl
end of the protein). No change in the signal sequence was
noted for CIN0309R, the only isolate sequenced complete-
ly in this region. Additional amino acid substitutions were
recorded for the brain-derived isolate. These included
Ile16Val, the signal sequence, and Arg502Lys, the trans-
membrane region sequence. Both N and P proteins were
highly conserved, with only 1 aa substitution at positions
37 and 64, respectively. Importance of the amino acid sub-
stitutions in these proteins in the pathogenesis of CHPV
infection remains to be determined. As modeled by Walker
and Kongsuwan (7), major antigenic sites for Vesicular
stomatitis virus (New Jersey) neutralization escape muta-
tions correspond to the CHPV G domain exhibiting multi-
ple amino acid changes in epitope VII (Thr219Ala and
Gly222Ala) and epitope VI (Arg264Lys and His269Pro).
Phylogenetic analyses based on G and P genes (Figure)
showed that the brain-derived isolate clustered with the
1965 isolate. No segregation of the isolates from
encephalitis and febrile cases was noted, regardless of the
type of the viral gene examined, a finding that suggests the
importance of host factors in influencing the outcome of
the infection. 
In conclusion, the present study shows that Chandipura
viruses isolated from human cases in India in 1965 and
2003 were not very divergent. Although several amino
acid differences were recorded in G protein, the impor-
tance of these changes in the pathogenesis of CHPV infec-
tion needs to be determined. Generation of infectious
cDNAclones for 1965 and 2003 isolates and assessment of
individual genes in the pathogenesis of CHPV infection
may help in understanding the relationship of structure to
outcome for CHPV infections.
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Figure. Phylogenetic analyses of complete G gene (A), P gene (B),
and N gene (C) of Chandipura virus isolates. For details on iso-
lates, see Table 2. Percent bootstrap support is indicated by the
values at each node. For G and P gene-based analyses, Piry virus
(GenBank accession no. D26175) was used as an outgroup. For
N gene, an unrooted tree was constructed because the sequence
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